Article Text

Download PDFPDF

Treatment of solid tumor with autologous natural killer cells in mouse models
  1. Nan-Shih Liao1
  1. Aff1 grid.28665.3f0000000122871366Academia Sinica Taipei Taiwan

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Meeting abstracts

Cancer immunosurveillance protects the host from outgrowth of tumor cells. Natural killer (NK) cell function positively associates with reduction of cancer risk and with better survival of gastrointestinal stromal tumor patients. We expanded murine NK cells and characterized their anti-tumor activity in vitro and in vivo. Adoptive transfer of the expanded NK cells into tumor-bearing mice reduced tumor burden in B16/OVA and B16/F10 melanoma and Lewis lung carcinoma models. The adoptive transfer treatment enhanced IFN-γ production by splenocytes of the B16/OVA-bearing mice. Moreover, multiple transfers significantly prolonged the survival of mice bearing B16/F10 tumors. These results indicate the potential of autologous NK cell therapy for solid tumors.